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Abstract
The outcome of malaria infection is determined, in part, by the balance of pro-inflammatory and regulatory immune
responses. Failure to develop an effective pro-inflammatory response can lead to unrestricted parasite replication, whilst
failure to regulate this response leads to the development of severe immunopathology. IL-10 and TGF-b are known to be
important components of the regulatory response, but the cellular source of these cytokines is still unknown. Here we have
examined the role of natural and adaptive regulatory T cells in the control of malaria infection and find that classical
CD4+CD25hi (and Foxp3+) regulatory T cells do not significantly influence the outcome of infections with the lethal (17XL)
strain of Plasmodium yoelii (PyL). In contrast, we find that adaptive IL-10-producing, CD4+ T cells (which are CD252, Foxp32,
and CD1272 and do not produce Th1, Th2, or Th17 associated cytokines) that are generated during both PyL and non-lethal
P. yoelii 17X (PyNL) infections are able to down-regulate pro-inflammatory responses and impede parasite clearance. In
summary, we have identified a population of induced Foxp32 regulatory (Tr1) T cells, characterised by production of IL-10
and down regulation of IL-7Ra, that modulates the inflammatory response to malaria.
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Introduction
The erythrocytic stage of malaria infection is characterised by
the development of strong pro-inflammatory immune responses
which, although required to control parasite replication and
promote clearance of infected erythrocytes, must be tightly
regulated to prevent the immune-mediated pathology which is
integral to the development of the severe complications of
infection in humans and in a number of well-characterised animal
models [1–3]. Previous studies have highlighted important roles
for IL-10 and TGF-b in regulating the pro-inflammatory response
during malaria infection [4–11]. Thus, although IL-102/2 and
TGF-b-depleted mice are able to control parasite replication
during P. chabaudi AS infection as effectively as WT mice, unlike
WT mice they develop severe TNF-mediated pathologies which
are typically fatal [4,9–11]. Similarly, IL-10 can prevent the onset
of cerebral malaria in P. berghei ANKA-infected mice [8].
However, the exact role of IL-10 and TGF-b appears to vary
between infections with different malaria species and strains,
depending on the timing of cytokine production in relation to
disease progression. Thus, production of TGF-b and IL-10 during
the first few days of a lethal P. yoelii 17XL (PyL) infection is
associated with inhibition of pro-inflammatory responses, rapidly
escalating parasitaemia and death [5,7]. In contrast, mice infected
with the non-lethal variant (P. yoelii 17X; PyNL) produce no or
only low levels of TGF-b and IL-10 during early acute infection
and eventually control their parasitaemia [5]. Blockade of IL-10R
signalling in combination with anti-TGF-b treatment restores the
type-1 immune response during lethal P. yoelii infection, and a
proportion of infected animals are able to control their infections
and survive [5]. Moreover, splenocytes from susceptible BALB/c
mice, but not resistant DBA/2 mice, infected with PyNL produce
IL-10 and TGF-beta during the early acute stage of infection,
which is associated with an increase in the proportion of splenic
CD25+ CD4 T cells [12]. Taken together, these studies
demonstrate a causal role for immunoregulatory cytokines in
suppressing parasite clearance mechanisms.
In accordance with these findings, a study by Hisaeda and
colleagues indicated that differential activation of natural regula-
tory T cells (nTreg) may account for the differing virulence of P.
yoelii strains, since depletion of CD4+CD25hi T cells (with anti-
CD25 antibody) prior to infection converted PyL from a rapidly
lethal infection into a resolving infection but had no effect on the
course of PyNL infection [13]. Although first identified as cells that
limit autoimmune pro-inflammatory responses [14], nTreg
(defined by expression of CD4, the transcription factor Foxp3
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and high levels of CD25) have since been shown to regulate the
immune response in a number infections including Leishmania spp
infections, Mycobacterium tuberculosis and helminth infections [15–
18], mediating their effects either via direct cell contact or by
release of cytokines. However, it is now becoming apparent that
both adaptive (Foxp32) regulatory T cell populations and classical
T-bet expressing Th1 cells also play crucial immunoregulatory
roles during infection and mediate their effects through secretion
of IL-10 [19–21].
In this study we have examined the generation and function of
both nTreg and adaptive IL-10-secreting T cells during malaria
infection. We observe equivalent expansion of natural Foxp3+
regulatory T cells during both lethal and non-lethal P. yoelii
infections but, using either anti-CD25 treatment or adoptive
transfer of purified CD25hi/Foxp3+ nTreg or CD252/Foxp32
non-Treg T cell populations, we find no role for nTreg during PyL
infection. Conversely, we demonstrate that populations of adaptive
regulatory CD4+ T cells, that are CD252, Foxp32 and CD1272,
and which do not make IFN-c, IL-4 or IL-17, develop during both
PyL and PyNL infections. These cells inhibit parasite clearance
but, importantly, also prevent the development of pathology via
production of IL-10. These data are consistent with the notion that
whilst endogenous populations of nTreg may be sufficient to
prevent immune-mediated pathology during chronic infections
which induce rather modest inflammatory responses, such as
avirulent leishmania, tuberculosis or helminth infections, rapid
induction of distinct populations of adaptive/Th1 CD4+ T cells
producing IL-10 may be required to counter the powerful
inflammatory signals provided by virulent, rapidly replicating
pathogens.
Results
Course of infection with PyL and PyNL in C57BL/6 mice
In accordance with previous observations [5,22], infection of
C57BL/6 mice with 104 P. yoelii 17XL (PyL) parasites was
associated with a rapid onset of fulminant parasitaemia (approach-
ing 100% by day 7 pi) that was universally fatal (Figure 1A, B). In
contrast, infection with 104 P. yoelii 17X (NL) (PyNL) parasites led
to a more gradual increase in parasitaemia with peak parasitaemia
of approx. 30% on day 14 pi, before the infection eventually
resolved. Significant differences in malaria-induced anaemia were
also evident between lethal and non-lethal infections, with more
rapid onset and increased severity of anaemia occurring in PyL-
infected mice compared with PyNL-infected mice (Figure 1C).
Figure 1. Course of infection of lethal (PyL) and non-lethal
(PyNL) P. yoelii in C57BL/6 mice. C57BL/6 mice were infected i.v.
with 104 P. yoelii 17XL (PyL) or P. yoelii 17X (PyNL) parasites. The course
of each infection was followed by monitoring (A) parasitaemia, (B)
survival and(C) anaemia. 4–5 mice per group. Results are representative
of 4 separate experiments. * = significant differences (p,0.05) between
PyL and PyNL.
doi:10.1371/journal.ppat.1000004.g001
Author Summary
Much of the pathology of malaria infection is due to an
excessive inflammatory response to the parasite. The
regulatory cytokine IL-10 is known to control inflammation
during malaria infections and thus protect against
immunopathology, but, in so doing, it reduces the
effectiveness of other immune mechanisms which remove
the parasites. In order to try to dissociate these two effects
of IL-10, to allow simultaneous control of infection and
avoidance of pathology, we need a better understanding
of the processes leading to IL-10 production, the timing of
its production, and the cells that produce it. In this study
we have found that the major source of IL-10 during
malaria (Plasmodium yoelii) infection is adaptive regulatory
CD4+ T cells. This population is distinct from natural
regulatory T cells and classical effector T cells. IL-10 derived
from these adaptive CD4+ T cells prevents hepatic
immunopathology but also suppresses the effector T cell
response, preventing parasite clearance. Further work is
now required to determine how these two key cell types
(anti-parasitic effector T cells and IL-10-producing regula-
tory T cells) are induced, so that vaccines can be designed
that will induce optimal numbers of each cell type at
appropriate stages of the infection.
T Cell Derived IL-10 Regulates Immunity to Malaria
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Similar expansion and activation of CD4+Foxp3+
regulatory T cells during PyL and PyNL infection
We have previously reported that simultaneous neutralisation of
TGF-b and blockade of IL-10 signalling allows a proportion of
PyL-infected mice to resolve their infections and survive [5],
suggesting that active immune regulation/immune suppression
occurs during PyL infection that inhibits optimal parasite control.
In agreement with these observations, Kobayashi et al [7] have
reported that IL-10 is produced very early during PyL (but not
during PyNL) infection and Perry et al [23] have reported a switch
from IL-12 (at day 3 pi) to IL-10 (at day 17 pi) production by
splenic dendritic cells during the course of a non-lethal Py
infection. These data are consistent with the hypothesis that
protective pro-inflammatory responses develop during the acute
phase of PyNL infection that limit parasite numbers, whereas an
early anti-inflammatory cytokine response during the acute phase
of PyL infection inhibits the development of protective immune
responses. As CD4+CD25+ regulatory T cells (nTreg) have been
reported to regulate immunity in a number of auto-immune and
infectious diseases [14–18] and can exert their regulatory role
through secretion of IL-10 and/or TGF-b we investigated, using
intracellular staining for Foxp3 as well as transgenic Foxp3-GFP
reporter mice [24], whether nTreg activation is correlated with the
virulence of PyL infection.
CD4+ splenic lymphocytes from uninfected (control) mice, or
from PyL- or PyNL- infected mice, were analysed for
intracellular Foxp3 expression (Figure 2A) and the numbers of
CD4+Foxp3+ cells, the expression levels of Foxp3 and the ratios
of CD4+Foxp3+ (nTReg) to CD4+Foxp32 (non-regulatory T
cells) were assessed over the first 7 days pi (Figure 2B–D). In
accordance with previous observations [25] a significant
increase in the numbers of splenic CD4+Foxp3+ nTreg was
observed during the first 5 days of PyL infection (Figure 2B)
and this was accompanied by increased levels (MFI) of Foxp3
expression (Figure 2C) and a transient increase (on day 3pi) in
the nTreg/non-Treg ratio (Figure 2D). However, almost
identical changes in nTreg numbers and Foxp3 expression
levels were observed in mice infected with PyNL, and there
were no significant differences in any nTreg parameter between
PyL-infected and PyNL-infected mice at any time up to
7 days pi, after which the PyL-infected mice succumbed to
their infections.
Similar results were obtained with Foxp3-GFP reporter mice
[24]. Importantly, the course of PyL and PyNL infections were
equivalent in Foxp3-GFP mice and C57BL/6 mice (data not
shown). A representative plot showing Foxp3-GFP expression in
infected and uninfected mice is shown in Figure 2E. Numbers of
CD4+GFP+ cells were significantly increased in the spleen on
5 day pi (Figure 2F) and on day 7 pi (data not shown) but did
not differ significantly between PyL-infected and PyNL-infected
mice. Finally, no significant differences were observed in
expression of Foxp3 mRNA in CD4+ T cells purified from
spleens of PyL and PyNL-infected mice on days 1, 3, 5 and 7 pi
(data not shown).
Figure 2. Expansion and activation of natural Foxp3+ regulatory T cell populations during PyL and PyNL infections. Numbers and
activation status of Foxp3+ regulatory T cells were determined on various days post-infection with PyL or PyNL in (A–D) WT mice or (E–F) Foxp3-GFP
transgenic mice. (A) Representative dot plot of intracellular staining in CD4+ T cells. On selected days post-infection with PyL or PYNL, splenic CD4+
lymphocytes were analysed for (B) numbers of Foxp3+ cells,(C) intensity (MFI) of Foxp3 staining and (D) ratio of Foxp3+ to Foxp32 cells. (E)
Representative dot plots showing GFP (Foxp3) expression in CD4+ splenocytes from 7 day PyL and PyNL-infected animals and uninfected controls. (F)
Numbers of splenic GFP+ (Foxp3+) CD4+ regulatory T cells on day 5 post infection. 3–5 mice per group. Results are representative of 3 independent
experiments. Symbols represent significant differences (p,0.05) between groups: # PyL vs PyNL; * PyL vs uninfected; , PyNL vs uninfected.
doi:10.1371/journal.ppat.1000004.g002
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Neither CD25hi nor Foxp3+ endogenous regulatory CD4+
T cells contribute to the virulence of lethal P. yoelii
infection
The similarity of the nTreg response during PyL and PyNL
infections suggested that, in our hands, suppression of effector cell
responses by nTreg was unlikely to explain the highly virulent
nature of PyL infections. However, to formally test the role of
nTreg, mice were treated with a cocktail of anti-CD25 antibodies
(previously shown to give optimal depletion of CD4+CD25hi-
Foxp3+cells; 25) 3 days prior to infection with PyL (Figure 3). As
previously reported [25], the 7D4 (IgM, anti-CD25) antibody
substantially reduced the proportion of splenic CD25+ CD4 cells
within 3 days (i.e day of infection) but CD25+ cells recovered to
normal levels by day 4 pi (results not shown) and 7D4 treatment
had no significant effect on the frequency of CD4+Foxp3+ve cells
(results not shown). In contrast, PC61 (IgG anti-CD25) given in
combination with 7D4 induced an approximately 50% reduction
in the frequency of both CD25+ and Foxp3+ cells that was
sustained throughout the 7 day infection period [25]. Nonetheless,
neither 7D4 treatment nor combined 7D4+PC61 treatment
significantly altered the course of parasitaemia, anaemia or
survival of PyL infection in C57BL/6 mice (Figure 3A–C). As
these observations contradict those of a similar published study
[13] we considered whether some effect of natural T reg might be
being masked by the rapidly ascending parasitaemia and early
mortality associated with infection with 104 PyL parasites. We
therefore repeated the anti-CD25 antibody treatment in C57BL/6
mice infected with either a 10 fold lower dose of PyL parasites (103
PyL) or with 104 PyNL parasites. However, anti-CD25 antibody
treatment did not alter the outcome of either of these infections
Figure 3. Natural Treg do not significantly contribute to the virulence of PyL infection. (A–C) Mice were given either a single dose of
0.75 mg 7D4 (IgM clone) or 0.25 mg 7D4 combined with 0.75 mg PC61 (IgG1 clone) on 3 days prior to infection with 104 PyL pRBC. The effect of anti-
CD25 treatment on the course of PyL infection was examined in (A–C) C57BL/6 mice by following (A) parasitaemia, (B) anaemia and (C) weight loss.
Groups consisted of 3–5 mice and data are representative of 2 independent experiments. Symbols represent significant differences (p,0.05) between
groups: (A–D) # 7D4 vs 7D4/PC61; * 7D4 vs PBS; , 7D4/PC61 vs PBS; (G–H) # 7D4 vs 7D4/PC61; * 7D4 vs 7D463; , 7D4 vs PBS; + 7D4/PC61 vs
7D463; W 7D4/PC61 vs PBS; D 7D463 vs PBS. (D–F) Naive CD4+CD252 (non-Treg) and CD4+CD25hi (Treg) cells were purified by flow cytometric cell
sorting and adoptively transferred alone or at a 10:1 ratio (non Treg:Treg) into RAG-12/2 mice prior to infection with PyL parasites. (D) shows the
purity of sorted CD4+CD252 and CD4+CD25hi populations prior to adoptive transfer and the relative expression of Foxp3 within the purified
populations. The affect of adoptive transfer on the course of infection was determined by monitoring (E) parasitaemia and (F) survival for the duration
of the experiment. Groups consisted of 5 mice and the results are representative of 2 independent experiments. Symbols represent significant
differences (p,0.05) between groups: # CD252 vs CD25+; * CD252 vs CD252/ CD25+; , CD252 vs control; + CD25+ vs CD252/ CD25+; W CD25+ vs
control; D CD252/ CD25+ vs control.
doi:10.1371/journal.ppat.1000004.g003
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(Figures S1 and S2) suggesting that natural T reg cells do not
markedly influence P. yoelii infections in C57/BL6 mice.
It has been reported that regulatory T cell responses are more
effective at limiting pro-inflammatory responses in BALB/c mice
than in C57BL/6 mice [26]. Therefore, to determine whether
mouse strain influences the outcome of anti-CD25 treatment
during PyL infection, we repeated the CD25-depletion experi-
ments in BALB/c mice and compared our depletion strategies
(single dose of 7D4 or 7D4+PC61 given 3 days prior to infection)
with a strategy previously shown to affect PyL infection [13],
namely repeated injections of 7D4 antibody on days23,21 and 5
relative to PyL infection. Repeated administration of 7D4 did not
increase either the duration of CD25+ T cell depletion or the
extent of depletion of CD4+Foxp3+ve cells compared to the other
treatment regimes (Figure S3). Consistent with this, repeated
administration of 7D4 did not alter the course of PyL infection
compared with single 7D4 administration or combined 7D4 and
PC61 administration (Figure S3), and none of our CD25-depletion
regimes had any effect on PyL infection in BALB/c mice (Figure
S3).
It is becoming increasingly evident that anti-CD25 antibody
treatment is not a specific or robust strategy to examine the
importance of natural regulatory T cells during inflammatory
episodes [25,27–29]. CD25 expression is not limited to nTreg
[24]. Moreover, depending on the precise protocol used, a variable
but significant proportion of Foxp3+ cells escape depletion by anti-
CD25 antibody. We therefore compared the outcome of PyL
infection in RAG2/2 mice reconstituted or not with purified
naı¨ve CD4+CD252 (putative effector) T cells or a 10:1 ratio of
effector (CD4+CD252) to nTreg (CD4+CD25+) cells. Further-
more, as nTreg can down-regulate NK cell responses [30], and as
NK cells have previously been reported to play a protective role
during malaria infection [31–33], we adoptively transferred
CD4+CD25+ (nTreg) cells in the absence of CD4+CD252
(effector) cells, to determine whether nTreg modulate innate
immune responses during malaria infection. The proportion of
Foxp3+ cells fell from 10–15% in unsorted CD4+ T cells to 1–2%
in the CD252CD4+ population, whereas CD25+ cells were highly
enriched for Foxp3+ cells (70–80%; Figure 3D).
In accordance with our previous studies [22], we found that
control (unreconstituted) RAG2/2 mice succumbed to PyL
infection with the same kinetics as WT mice (compare Figure 3E,
F with Figure 1). Furthermore, the course of infection was vir-
tually indistinguishable in RAG2/2 mice reconstituted with
CD4+CD252, CD4+CD25+ or a 10:1 ratio of CD4+CD252/
CD4+CD25+ T cells (Figure 3E, F). Thus, using two independent
models of nTreg depletion, we have found no significant role for
natural CD4+CD25+Foxp3+ regulatory T cells in suppression of
anti-parasitic immunity during PyL infection in either C57BL/6
or BALB/c mice.
PyL- and PyNL-induce IL-10 production from CD4+,
CD252, Foxp32 T cells that express low levels of IL-7Ra
Having found no evidence that nTreg influence the outcome of
PyL infection we next investigated the possibility that IL-10
producing CD4+ T cells (‘‘adaptive’’ Treg or Tr1 cells) might be
induced during PyL and/or PyNL infection that regulate parasite
killing and/or pathology.
Expression of IL-10 mRNA was determined by real time PCR
in purified splenic CD4+ T cells obtained on days 1, 3, 5 and 7
post-infection from wild type (WT) C57/BL6 mice and plasma
levels of IL-10 were determined by ELISA on days 1, 3, 5 and 7 pi
from WT and RAG2/2 mice. We find that CD4+ T cells are a
significant source of IL-10 by day 5 of both PyL and PyNL
infections, since IL-10 mRNA is significantly upregulated in
splenic CD4+ cells on days 5 and 7 post-infection compared with
cells from uninfected mice (Figure 4A). Furthermore, CD4+ T cells
(and potentially B cells) may be the major source of IL-10 during
infection since plasma IL-10 does not increase above baseline
levels in RAG2/2 mice (Figure 4B, C) except on day 3 pi of PyL
infection.
Figure 4. CD4+ T cells are a major source of IL-10 during both
PyL and PyNL infection. (A) On selected days post-infection, CD4+ T
cells were purified from PyL and PyNL infected mice by MACS sorting
and levels of IL-10 mRNA were determined by real time PCR (Taqman)
relative to the house keeping gene GAPDH. The results are shown as
the fold change in expression relative to uninfected naı¨ve CD4+ T cells.
In separate experiments the levels of IL-10 in the plasma of WT and
RAG-12/2 mice were determined by ELISA on selected days of (B) PyL
and (C) PyNL infection. Groups consisted of 3–5 mice and the results are
representative of 2 separate experiments. For Taqman analysis, purified
cells from several mice in each group were pooled; no significant
differences between groups were identified. * indicates significant
differences (p,0.05) between WT and RAG-12/2 infected mice.
doi:10.1371/journal.ppat.1000004.g004
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To more accurately determine the cellular source of IL-10
during P. yoelii infection, splenocytes from IL-10-GFP reporter
mice [21] were examined for expression of GFP and various cell
surface markers on selected days after PyL or PyNL infection
(Figure 5A–C). In both infections, from day 5 onwards, the vast
majority of the IL-10+ cells were CD4+ lymphocytes. At no
point during either PyL or PyNL infection did we observe
significant IL-10 production by myeloid (CD11b+), lymphoid
dendritic cells (CD11c+) or macrophages (F4-80+) (results not
shown). IL-10 production by CD19+ B cells was observed, on
day 7 post-infection, only during PyL but not PyNL infection
(results not shown). Moreover, IL-10 producing non-CD4+ T
cells produced only low quantities of IL-10, whereas CD4+ T
cells were heterogeneous in their ability to produce IL-10
(Figure 5A).
Since it is not possible to stain for intranuclear Foxp3 without
quenching the fluorescence of GFP, IL-10/GFP+ CD4+ T cells
were analysed for expression of CD25, CD62L and CD127 and
separately analysed for CD25 and Foxp3 (Figure 5B, C). On day 5
post-infection, IL-10+ CD4+ T cells showed very variable
expression of CD25 with approx. 60% being CD252, indicating
that they are not a typical nTreg population. As we have
previously observed transient upregulation of CD25 on
CD4+Foxp32 T cells at this time (Figure 5B and [22]), we
considered it likely that at 5 days post-infection the majority of IL-
10+ cells were Foxp32. In confirmation of this, by day 7 post-
infection, IL-10+ CD4+ T cells were almost exclusively CD252
indicating that, since the majority of Foxp3+ cells maintain CD25
expression during P. yoelii infection (Figure 5B), CD252Foxp32
CD4+ T cells are the primary source of IL-10 during both PyL and
PyNL infection. Interestingly the frequencies and numbers of IL-
10+ CD4+TCR-b+ cells were equivalent in PyL and PyNL infected
mice on day 7 post-infection (Figure 5D).
IL-10+ cells were heterogeneous in terms of expression of
CD62L suggesting that they comprise of a mixed population of
cells in terms of memory/activation status, and despite being
Foxp32, the majority of IL-10+ CD4+ cells were CD1272,
suggesting that down-regulation of IL-7Ra may be a useful marker
for differentiating adaptive Treg from other antigen-experienced
T cells (Figure 5C).
Figure 5. CD127low Foxp32 CD4+ T cells that do not constitutively express CD25 are the major source of IL-10 during P. yoelii
infection. Transgenic, IL-10-GFP knockin tiger mice were infected with PyL or PyNL. (A) Splenic lymphocytes from infected or uninfected control
mice were analysed for expression of CD4+ and GFP. (B,C) 7 days post infection, splenic CD4+ T cells were analysed for (B) expression of CD25 and
Foxp3, or (C) GFP (IL-10) and CD25, CD69, CD62L or CD127. (D) The frequency and number of GFP+ (IL-10+) CD4+ T cells was calculated 7 days post
infection in infected or uninfected mice. Groups consisted of 3–5 mice and the results are representative of 2 independent experiments.
doi:10.1371/journal.ppat.1000004.g005
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CD4+ T cells that produce IL-10 during malaria infection
are not classical nTreg, Th1, Th2, or Th17 cells
We have shown that CD4+ T cells are the primary source of IL-
10 during malaria infection, and that these cells do not express
CD25, suggesting that they may not be conventional nTreg cells.
Since IL-10 can be produced by various effector CD4+ T cell
subsets (including Th1, Th2 and Th17 cells), as well as specialised
regulatory populations such as Tr1 [19, 20 34–36], we examined
the expression of Th1, Th2 and Th17 lineage-associated cytokines
in IL-10-producing (GFP+) and IL-10-GFP2 CD4+ T cells purified
from IL-10-GFP reporter mice on day 7 of infection. As seen
previously (Figure 5), GFP expression was similar in CD4+ T cells
isolated from PyL and PyNL infected mice (Figure 6A). As
expected, IL-10 mRNA was expressed at much higher levels in
GFP+ than in GFP2 cells but cells isolated from PyL and PyNL
infected animals expressed similar levels of IL-10 mRNA
(Figure 6B). Importantly, Foxp3 mRNA was not upregulated in
IL-10-GFP+ cells isolated during either PyL or PyNL infection,
confirming that the IL-10-producing CD4+ T cells that develop
during P. yoelii infection are neither natural nor induced Foxp3+
regulatory T cells. Moreover, GFP+ cells did not express significant
amounts of mRNA for IFN-c, IL-4 or IL-17, thus distinguishing
them from classical Th1, Th2 and Th17 cells. Although IL-10-
GFP+ cells expressed IL-13 mRNA, levels were comparable to
those seen in GFP2 cells indicating that IL-10 producing cells did
not preferentially co-produce IL-13. Thus, the IL-10-producing
CD4+ T cells induced during P. yoelii infection fit the definition
[35] of adaptive, Tr1, regulatory T cells.
IL-10 from CD4+ T cells inhibits parasite killing during
infection
To determine whether IL-10 production from T cells is
functionally important during Py infection, we first compared
the course of PyL and PyNL infection in IL-102/2 and WT mice
(Figure 7). PyNL infection was significantly attenuated - with
significant reductions in parasitaemia and anaemia in IL-102/2
mice compared with WT mice (Figure 7A–D), although the IL-
102/2 mice did lose significantly more weight than age-matched
WT mice (Figure 7C). Furthermore, approx 30% (6/21 mice) of
IL-102/2 (but not WT) mice infected with 104 PyL pRBC were
able to control their infections and survived (Figure 7E–H), with
parasitaemia declining from a peak of approx 45% on day 6pi.
Moreover, IL-102/2 (but, again, not WT) mice given a low dose
PyL infection (103 pRBC) were fully able to control parasitaemia
and 100% of the mice survived (Figure 7I–L).
Taken together, these data indicate that IL-10 suppresses
immune effector mechanisms which would otherwise be able to
control low dose PyL infections. Since this IL-10 emanates
Figure 6. IL-10 producing CD4+ T cells that develop during P. yoelii infection are Tr1 cells and not Th1, Th2, or Th17 cells. Splenic
CD4+ T cells were isolated from transgenic IL-10-GFP mice on day 7 of PyL or PyNL infection and were purified by flow cytometric cell sorting into
GFP+ (IL-10+) and GFP2 (IL-102) populations. (A) shows the purity of the purified GFP+ and GFP2 populations. (B) Expression of IL-10, Foxp3, IFN-c, IL-
4, IL-13 and IL-17A mRNA was determined by real time PCR (Taqman) relative to the house keeping gene, GAPDH. The results are shown as the fold
change in expression relative to uninfected naı¨ve CD4+ T cells. For Taqman analysis, purified cells from several mice in each group were pooled.
doi:10.1371/journal.ppat.1000004.g006
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principally from CD4+ T cells (Figure 5) we hypothesised that
IL-10-deficient CD4+ T cells may promote more effective
parasite control than WT CD4+ T cells. To test this, purified
naı¨ve WT or IL-102/2 CD4+ T cells were adoptively
transferred into RAG2/2 mice which were then infected with
PyNL or PyL parasites.
PyNL-infected RAG2/2 mice that had received IL-102/2
CD4+ T cells developed significantly lower parasite burdens than
those which had received WT CD4+ T cells (Figure 8A). Although
both groups developed similar levels of anaemia, mice that
received IL-102/2 T cells lost significantly more weight and
succumbed to infection more rapidly than mice that received WT
CD4+ T cells (Figure 8B–D). Exacerbation of disease despite
improved parasite control in mice receiving IL-102/2 CD4+ T
cells was associated with more extensive proliferation of the
adoptively transferred T cells (IL-102/2 T cells comprised .30%
of total splenic leucocytes compared with ,10% for transferred
WT cells), higher concentrations of circulating IFN-c and lower
plasma concentrations of IL-10 (data not shown). These data are
consistent with the conclusion that recipients of IL-102/2 CD4+ T
cells died of immunopathology whilst recipients of WT CD4+ T
cells eventually died because they were unable to fully resolve their
infections.
By contrast, RAG2/2 mice that had received IL-102/2 CD4+
T cells were somewhat better able to control infections with 103
(8E–H) or 104 (8I–L) PyL infections than were mice receiving WT
CD4+ T cells; a proportion of mice receiving IL-102/2 T cells
were able to control their infections, although failure to fully
eliminate parasites eventually led to death from anaemia. Thus,
IL-10 derived from CD4+ T cells significantly modulates the
outcome of both PyL and PyNL infection.
IL-10 protects against immune pathology during P. yoelii
infection
It has previously been shown that IL-102/2 mice succumb to
normally avirulent P. chabaudi chabaudi infections despite compara-
ble - or more effective - control of malaria parasitaemia compared
to WT mice [9]. The increased susceptibility of IL-102/2 mice
is due to elevated plasma concentrations of IFN-c and TNF-a
[10] and survival of IL-102/2 mice following malaria infection
can be enhanced by treatment with anti-TNF-a [10]. Whilst
there was no marked difference in mortality between P. yoelii-
infected IL-102/2 and WT mice, IL-102/2 mice (and RAG2/2
mice reconstituted with IL-102/2 T cells) lost significantly
more weight than mice reconstituted with WT T cells during
Figure 7. IL-10 impedes parasite clearance during both PyL and PyNL infection. The course of infection with (A–D) PyNL and (E–L) PyL in
mice given (A–H) 104 pRBC’s or (I–L) 103 pRBC’s was compared in WT and IL-102/2 mice by monitoring (A, E, I) parasitaemia (B, F, J) anaemia, (C, G, K)
weight loss and ( D, H, L)survival. Groups consisted of 4–5 mice and the results are representative of 4 independent experiments. * indicates
significant differences (p,0.05) between WT and IL-102/2 infected mice.
doi:10.1371/journal.ppat.1000004.g007
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PyNL infection, indicative of more severe morbidity (Figure 7C,
8C).
Histopathological examination of infected animals did not
reveal any liver or lung damage 3 days post-infection (data not
shown) but revealed significantly more hepatic cellular changes
including periportal inflammation, necrosis and bridging necrosis
in IL-102/2 mice than in WT mice on days 7 and 14 post-
infection (Figure 9A) and this was significantly more severe in PyL-
infected than PyNL-infected animals on day 7 post-infection. We
also found that by day 25 of PyNL infection, RAG2/2 recipients
of IL-102/2 CD4+ T cells had developed significantly more severe
hepatic periportal inflammation and necrosis (including bridging
necrosis) than RAG2/2 recipients of WT CD4+ T cells (Figure 9B).
Thus, T cell derived IL-10, although negatively regulating parasite
killing, is protective during malaria infection by preventing the
onset of immunopathology.
Discussion
It is well established, in a variety of infections, that regulatory
cytokines both ameliorate immunopathology and delay pathogen
clearance [5,8,9–11,37–42]. Manipulation of these cytokines by
vaccination or immunotherapy, to simultaneously enhance
pathogen clearance and limit the associated pathology, requires
a better understanding of their cellular sources and mechanisms of
induction. Important roles have been demonstrated for both IL-10
[6–11] and TGF-b [4,5] in modulating the outcome of murine
malaria infections, and observational data strongly suggests that
they play a similar role in human infections [43–45]. Recently,
endogenous or natural, CD25hi, Foxp3+ CD4+ T cells (nTreg)
have been implicated as major regulators of malarial pathology
[13,46] but their mechanisms of action remain undefined.
Attempting to elucidate the role of nTreg in murine Plasmodium
yoelii infections, we were surprised to find no role for these cells in
regulating the outcome of either high dose (104) or lower dose (103)
lethal (Py17XL; PyL) or non-lethal (Py17X; PyNL) infection in
either C57BL/6 or BALB/c mice. In contrast, we find that
adaptive, IL-10-producing CD4+ Tr1 cells (CD252, Foxp32,
CD1272, IFN-c2, IL-42 and IL-172), are generated during both
PyL and PyNL infections and are associated with down-regulation
of pro-inflammatory responses, moderation of both morbidity and
mortality and failure to clear parasites. Crucially, we were able to
demonstrate a causal relationship between these various observa-
tions by showing that IL-102/2 CD4+ T cells adoptively
transferred into RAG2/2 mice provided more effective parasite
control than did WT CD4+ T cells, but at the cost of more severe
pathology.
Figure 8. T cell-derived IL-10 inhibits parasite clearance during PyL and PyNL infections. Prior to infection with (A–D) PyNL and (E–L) PyL
with (A–H) 104 or (I–L) 103 pRBC’s, RAG-12/2 mice received naı¨ve CD4+ T cells that had been purified from either WT or IL-102/2 mice by magnetic
bead sorting. The course of infection was followed by monitoring (A, E, I) parasitaemia (B, F, J) anaemia and (C, G, K) weight loss and (D, H, L) survival.
Groups consisted of 4 mice and the results are representative of 2 independent experiments. * indicates significant differences (p,0.05) between
mice receiving WT and IL-102/2 CD4 T cells.
doi:10.1371/journal.ppat.1000004.g008
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We conclude that induced Foxp32 regulatory T cells,
characterised by down-regulation of CD127/IL-7Ra, modulate
the inflammatory response to Plasmodium yoelii malaria by
production of IL-10. Although it has been observed in humans
[47,48] and mice [48] that CD127 is down-regulated on
endogenous (Foxp3+) regulatory T cells, our data demonstrate –
for the first time - that CD127 is also down-regulated on adaptive
(Foxp32) Tr1 cells.
The lack of any effect of anti-CD25 antibody treatment on the
course of PyL infection in our experiments contradicts the
published data [13,46]. Despite numerous attempts, using three
different depletion protocols - including a protocol identical to that
previously reported to ameliorate PyL infection [13], in both
C57BL/6 and BALB/c mice we were unable to reproduce the
published observations. Anti-CD25 treatment failed to ameliorate
PyL infection initiated by a 10 fold lower dose of parasites,
discounting the possibility that the virulence of high dose PyL
infection masks regulatory activity of nTreg that would otherwise
be evident during a less virulent infection. Furthermore, adoptive
transfer of CD25+ and/or CD252 CD4+ T cells into RAG2/2
mice also failed to reveal any role for CD25+ Foxp3+ cells in this
infection. The discrepancy between our findings and those of other
labs is reminiscent of the disparate results obtained for P. berghei
ANKA infection which report that depletion of CD25+ regulatory
cells either facilitates parasite control and prevents the onset of the
cerebral pathology infection in C57BL/6 mice [49], or enhances
effector T cell responses and increases the severity of brain
pathology in normally resistant BALB/c mice [50] or has no effect
on cerebral pathology [51]. One explanation for these inconsistent
results may be differences in prior exposure to pathogens or
commensal organisms between mice in different laboratories.
Components of the normal intestinal flora of conventionally
housed animals are essential for development of intestinal nTreg
[52] and nTreg development is facilitated by the presence of
covert infections such as Helicobacter hepaticus [53]. Depletion of
nTreg by anti-CD25 treatment in such mice may lead to more
profound alteration in the effector / regulatory cell balance than in
mice (such as those used in our studies) raised in low-infection
environments.
Although, we could show no role for nTreg in acute PyL and
PyNL infection, we have shown that the adaptive IL-10-
producing regulatory T cells that develop during P. yoelii
infection hinder parasite control but simultaneously limit disease
severity. In contrast to recent studies describing a role for IL-10
producing Th1 cells in Toxoplasma gondii [20] and Leishmania spp
[19,54,55] infections, the adaptive IL-10 producing Tregs we
describe do not co-express IFN-c or other effector cytokines and
better fit the definition of Tr1 cells. Nevertheless in several
virulent protozoal infections (PyL, Toxoplasma gondii, Leishmania
major SD and L. donovani), adaptive IL-10-producing CD4+ T
cells are required to regulate the fulminant Th1-effector
responses that are induced whereas classical (Foxp3+) Treg
appear to be sufficient to regulate the effector response to a less
virulent (healing) strain of L. major [15]. Given that naı¨ve CD4+
T cells can develop into adaptive Treg after interaction with IL-
10-producing dendritic cells expressing low levels of co-
stimulatory molecules [56–59], it is possible that the induction
of Treg during P. yoelii infection is linked to the modulation of
macrophage and dendritic cell function that occurs in response
to prolonged toll-like receptor signalling [60]. Alternatively,
parasite-induced TGF-b [40,60], IL-6 [44] and/or IL-27 may
synergise to promote production of IL-10 by Th1, Th2, Th17
and Tr1 cells [34,36,61,62].
We have not yet definitively identified the mechanism by which
IL-10 suppresses parasite clearance but given our recent findings
that control of the acute phase of P. yoelii parasitaemia is critically
dependent on macrophages [22], it is likely that T cell-derived IL-
10 acts directly on macrophages to inhibit their anti-parasitic
mechanisms. It is also possible that, as in mycobacterial infections,
adaptive Treg induce an autocrine signalling loop in which
macrophages both secrete and respond to IL-10 with consequent
down regulation of effector function and pathology via a STAT-3
–dependent pathway [63–66].
In summary, we have demonstrated that adaptive, but not
natural, regulatory T cells control parasite numbers during PyL
and PyNL infections whilst also limiting the onset of
immunopathology. These cells are characterised by lack of
expression of CD25 and Foxp3, down-regulation of CD127 and
production of IL-10 but not IFN-c, IL-4 or IL-17. Taken
together with our data highlighting the importance of macro-
phages in the control of malaria infection [22], these findings
identify an important pathway of adaptive, T cell- mediated
control of innate immune responses. Further studies are
required to identify the pathways leading to induction of this
important regulatory cell population.
Materials and Methods
Mice and parasites
C57BL/6, Foxp3-GFP (F2: 129/C57BL/6; from A. Rudensky,
University of Washington, 24), C57BL/6 RAG-12/2, C57BL/6
IL-102/2 and BALB/c mice were bred in-house or purchased
from Harlan and maintained under barrier conditions at LSHTM.
IL-10-GFP reporter mice [21] were maintained under barrier
conditions at the National Institutes of Health. Cryopreserved
Plasmodium yoelii 17X (non lethal; PyNL) and P. yoelii 17XL (lethal;
PyL) parasites were passaged once through mice before being used
in experimental animals.
Figure 9. IL-10 ameliorates hepatic pathology during PyL and
PyNL infection. Liver pathology was examined (A) in WT and IL-102/2
mice that were either uninfected or had been infected with P. yoelii
7 days (PyL, PyNL) or 14 days (PyNL) previously, (B) on day 25 post-
infection with PyNL in RAG-12/2 mice reconstituted with either WT or
IL-102/2 CD4+ T cells prior to infection. Groups consisted of 4–5 mice
and the slides shown are representative of mice from 2 independent
experiments. Arrows highlight areas of interest: c = central vein
periportal infiltration, pv = vessels packed with inflammatory cells,
p = pigmented kupffer cells, n = necrosis, i = inflammation in parench-
ymia, pt = necrosis and gross infiltration in portal triad.
doi:10.1371/journal.ppat.1000004.g009
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Unless stated otherwise, male or female mice, 7–9 weeks of age,
were infected intraveneously with 16 103 or 16 104 parasitised
red blood cells (pRBC). Parasitaemia was determined daily by
examination of Giemsa-stained thin smears of tail blood for the
first seven days of infection and every second day thereafter. On
every second day, mice were weighed and RBCs were counted
using an automated haemoanalyser (Beckman Coulter). Plasma
was stored (at 220uC) for cytokine quantification. On selected
days post-infection, mice were sacrificed and spleens were
removed. Single spleen cell suspensions were prepared by
homogenisation through a 70 mm cell strainer (BD Biosciences)
and live cells enumerated by trypan blue exclusion.
Cell sorting
CD4+ T cells were positively selected using anti-mouse CD4-
conjugated midiMACS beads (Miltenyi Biotec) according to the
manufacturer’s instructions and the purity of eluted cells was
checked by flow cytometry. In some experiments, the CD4+ cells
were labelled with anti-mouse CD4 (GK1.5: Rat IgG2b: E-
bioscience) and anti-mouse CD25 (PC61: Rat IgG1: E-bioscience)
fluorochrome-labelled antibodies and sorted, using a BD FACS-
Vantage SE, into CD4+CD25+ and CD4+CD252 populations. In
separate experiments CD4+ T cells, isolated from IL-10-GFP
reporter mice [21] on day 7 of infection, were labelled with anti-
mouse CD4 (GK1.5: Rat IgG2b: E-bioscience) and IL-10
producing (GFP+) and non-IL-10 producing (GFP2) CD4+ T
cells were purified by flow cytometric cell sorting.
Real time PCR
IL-10, Foxp3, IFN-c, IL-4, IL-13 and IL-17A mRNA were
quantified by Taqman (ABI, Warrington, UK). RNA was
extracted (RNAeasy) and DNAse1 treated prior to cDNA
synthesis. cDNA expression for each sample was standardised
using the housekeeping gene GAPDH. Cycling conditions were:
initialisation 2 min at 50uC and 10 min at 95uC followed by 40
cycles of 15 sec at 95uC and 1 min at 60uC.
Primer sequences:
IL-10 Forward ATGCTGCCTGCTCTTACTGACTG
Reverse CCCAAGTAACCCTTAAAGTCCTGC,
Foxp3 Forward CACCTATGCCACCCTTATCC,
Reverse CGAACATGCGAGTAAACCAA
IFN-c Forward AGA GCC AGA TTA TCT CTT TCT
ACC TCA G
Reverse CCT TTT TCG CCT TGC TGT TG
IL-4 Forward ACG AGG TCA CAG GAG AAG GGA
Reverse AGC CCT ACA GAC GAG CTC ACT C
IL-13 Forward CCTCTGACCCTTAAGGAGCTTAT
Reverse CGTTGCACAGGGGAGTCT
IL-17A Forward TGTGAAGGTCAACCTCAAAGTC
Reverse AGGGATATCTATCAGGGTCTTCATT
Cytokine ELISA
Rat anti-mouse IL-10 (JES5-2A5; Rat IgG1; Mabtech, Sweden)
or rat anti-mouse interferon (IFN)-c (AN-18; Rat IgG1;
eBioscience) antibodies were used as capture antibodies, diluted
in 0.5 M Tris-HCl, pH 8.9 buffer. Biotinylated rat anti-mouse IL-
10 MAb (JES5-16E3; Rat IgG2b; Mabtech) or rat anti-mouse IFN-
c MAb (R4-6A2; Rat IgG1; Mabtech) were used as detecting
antibodies and were visualised using streptavidin-alkaline phos-
phatase (eBioscience) and p-nitrophenyl phosphate (Sigma Aldrich,
UK). Absorbance was read at 405 nm using a MRX TC II
microplate reader (Dynex Technologies Ltd,. UK)
Flow cytometry
For flow cytometric analysis, cells were surface stained with anti-
mouse CD4 (RM4-5; Rat IgG2a; BD Biosciences), anti-mouse
CD25 (PC61; Rat IgG1; eBioscience), anti-mouse CD69 (H1.2F3;
Armenian Hamster IgG; eBioscience), anti-mouse CD62L (MEL-
14; Rat IgG2a; eBioscience) or anti-mouse CD127 (A7R34; Rat
IgG2a; eBioscience). Intracellular Foxp3 staining using anti-mouse
Foxp3 (FJK-16s; Rat IgG2a; eBioscience) was performed by
permeabilising cells with 0.1% Saponin/PBS. Cells were concur-
rently incubated with anti-mouse CD16/32 (Fc block) when
staining with all conjugated antibodies. Flow cytometric acquisi-
tion was performed using a FACSCalibur (BD Immunocytometry
Systems, USA) and all analysis was performed using Flowjo
software (Treestar Inc., OR, USA)
Histopathology
Liver and lung tissues were fixed in 10% Formalin-saline. Fixed
tissues were paraffin embedded and stained with haematoxylin
and eosin. Slides were microscopically examined at 20X
magnification.
Statistical analysis
Statistical significance was determined using Student’s T test,
unless otherwise stated, with P,0.05 taken as indicating a
significant difference.
Supporting Information
Figure S1 Anti-CD25 antibody administration does not
affect the outcome of low dose PyL infection. C57BL/6
mice were treated with either a single dose of 0.75 mg 7D4, or
with 0.25 mg 7D4 combined with 0.75 mg PC61, 3 days prior to
infection with 103 PyL parasites. The course of PyL in anti-CD25
antibody-treated mice and control mice was then followed by
monitoring (A) parasitaemia, (B) anaemia and (C) mortality. #
indicates significant differences (P,0.05) between 7D4 and 7D4 +
PC61 treated mice. No significant differences were observed
between the other groups of mice. Groups consisted of 4 mice and
the results are representative of 2 independent experiments.
Found at: doi:10.1371/journal.ppat.1000004.s001 (0.02 MB TIF)
Figure S2 Anti-CD25 antibody administration does not
affect the outcome of PyNL infection. C57BL/6 mice were
treated with either a single dose of 1 mg PC61 7 days prior to
infection with PyNL (Expt 1) or with a single dose of 0.75 mg 7D4
or 0.25 mg 7D4 combined with 0.75 mg PC61 on the day of
PyNL infection (Expt 2). The course of PyNL in anti-CD25
antibody-treated mice and control mice was then followed by
monitoring (A, D) parasitaemia, (B, E) anaemia and (C, F) weight
loss. No mortality occurred in any of the groups during either
experiment. * indicates significant differences (P,0.05) between
PC61 treated and control mice. No significant differences were
observed between 7D4, 7D4 + PC61 treated mice and control
mice. Groups consisted of 3–5 mice per group.
Found at: doi:10.1371/journal.ppat.1000004.s002 (0.02 MB TIF)
Figure S3 Anti-CD25 antibody administration does not
affect the outcome of PyL infection in BALB/c mice. -
BALB/c mice were treated with either a single dose of 0.75 mg
7D4, or with 0.25 mg 7D4 combined with 0.75 mg PC61, 3 days
prior to infection with 104 PyL pRBC or with 3 repeated
injections of 0.5 mg 7D4 on days 23, 21 and +5 relative to PyL
infection. The efficiency of depletion of CD25+ and Foxp3+
CD4+ T cells was determined in peripheral venous blood by
measuring the expression of (A) CD25 and (B) Foxp3 on CD4+ T
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cells. The course of PyL in anti-CD25 antibody-treated mice and
control mice was then followed by monitoring (C) parasitaemia,
(D) anaemia and (E) mortality. Symbols represent significant
differences (p,0.05) between groups: , 7D4 vs PBS, W 7D4/
PC61 vs PBS, + 7D4/PC61 vs 7D4 x3, # 7D4 vs 7D4/PC61.
Groups consisted of 5 mice.
Found at: doi:10.1371/journal.ppat.1000004.s003 (0.15 MB TIF)
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